Current Research Studies

A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures

Epidiolex in Focal Onset Seizures

  • Condition(s): Other
  • Phase: I
  • Clinicaltrials.gov ID: NCT07233239

What is the goal of the study?

This study will enroll participants with FOS. Focal-onset seizures, or focal seizures (formerly known as partial seizures), are a common type of seizure characterized by excessive abnormal electrical activity originating in one or more specific regions of the brain.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: